r Abnormal mitochondrial morphology and function in cardiomyocytes are frequently observed under persistent G q protein-coupled receptor (G q PCR) stimulation.
Introduction
Mitochondria are dynamic organelles that continuously change their shape, size, number and location in response to various stimuli and metabolic demands in mammalian cells (Detmer & Chan, 2007; Kanamaru et al. 2012; Galloway et al. 2012b; Roy et al. 2015) . A balance of mitochondrial fission and fusion dictates mitochondrial shape and is believed to be critical for maintaining mitochondrial and cellular function under both physiological and pathophysiological conditions (Galloway et al. 2012b; Roy et al. 2015) . While mitochondrial morphology and dynamics are well-correlated with their metabolic activity under physiological conditions (Galloway et al. 2012b) , disruption of mitochondrial morphology by unbalanced fission and fusion has adverse consequences on mitochondrial functions in various cell types, leading to overproduction of reactive oxygen species (ROS) and activation of mitochondrial permeability transition pore (mPTP) (Yu et al. 2006 (Yu et al. , 2008 (Yu et al. , 2011 . Furthermore, mitochondria with abnormal shapes (i.e. small and fragmented mitochondria) are frequently present in various human diseases such as neurodegeneration, neuropathies and diabetes mellitus (Liesa et al. 2009; Archer, 2014) . In general, mitochondrial dynamics and shape are regulated by high-molecular weight GTPases including mitofusin1/2 (Mfn1/2), optic atrophy 1 (OPA1) and dynamin-like/related protein 1 (DLP1/Drp1) (Detmer & Chan, 2007; Liesa et al. 2009; Archer, 2014) . Mfn1/2 are located in the outer mitochondrial membrane (OMM) and regulate OMM fusion, whereas OPA1 is located in the inner mitochondrial membrane (IMM) and contributes to IMM fusion. DLP1/Drp1 mostly resides in the cytoplasm at rest, but small amounts of DLP1 are recruited to the OMM, oligomerized at the OMM, and provide mechanical force for tubule constriction and fission via their GTPase activity (Detmer & Chan, 2007; Liesa et al. 2009; Archer, 2014) . In the heart, mitochondrial fission and fusion proteins are highly expressed, especially in healthy cardiac muscles (Dorn, 2013; Piquereau et al. 2013) . Moreover, using transgenic mice with cardiac-specific deletion of fission (DLP1) or fusion (Mfn1/2 and OPA1) proteins, several groups have shown that the deletion of these proteins causes significant changes in cardiac mitochondrial morphology and function, as well as cardiac dysfunction in response to stress in vivo (Chen et al. 2011; Papanicolaou et al. 2012; Piquereau et al. 2012; Shirakabe et al. 2016) , suggesting that regulation of the expression of these fission/fusion proteins in cardiomyocytes is important for maintaining normal cardiac function. However, it is still unclear how the activity and function of fission/fusion proteins are post-translationally regulated under physiological and pathophysiological conditions. Abnormal mitochondrial morphology is frequently observed in patients with heart failure (HF) (Schaper et al. 1991) and in various animal HF models without significant changes in the expression of fission/fusion proteins (Elas et al. 2008; Dai et al. 2013; Czarnowska et al. 2016) , suggesting the existence of signalling molecules (e.g. kinases) that regulate mitochondrial morphology via post-translational modifications of fission/fusion proteins under HF. For instance, one of the major actions of chronic activation of G q protein-coupled receptor (G q PCR) signalling, including α 1 -adrenoceptor (α 1 -AR) in cardiomyocytes, is promotion of hypertrophy, but apoptotic pathway activation is also reported (Adams et al. 2000; Pu et al. 2003; Lu et al. 2009; O-Uchi et al. 2014 ). We and others have shown that the downstream kinases of G q PCR signalling, including protein kinase C (PKC) (Qi et al. 2011) , Ca 2+ /calmodulin-dependent protein kinase II (CaMKII) (Joiner et al. 2012; Xu et al. 2016 ) and proline-rich tyrosine kinase 2 (Pyk2) (O-Uchi et al. 2014) , phosphorylate mitochondrial proteins, which initiates mitochondrial ROS production and activates apoptotic signalling in cardiomyocytes. However, the detailed molecular mechanisms underlying G q PCR-mediated apoptotic pathways are not as well defined as those in hypertrophic pathways.
Another G q PCR downstream kinase, protein kinase D (PKD), belongs to a family of serine/threonine protein kinases downstream of PKC and is activated by G q PCRs including α 1 -AR (Steinberg, 2012) . PKD has three isoforms (PKD1-3), of which PKD1 is the main isoform abundantly expressed in ventricular cardiomyocytes (Avkiran et al. 2008; Steinberg, 2012) . Members of the PKD family regulate physiological functions in the heart, such as cardiac contraction, by phosphorylating myofilament proteins such as troponin (Avkiran et al. 2008) . Conversely, PKD is required for the progression of pathological cardiac hypertrophy and HF, as it translocates to the nucleus and phosphorylates downstream target proteins such as histone deacetylase 5 (HDAC5), which leads to the re-expression of fetal genes that accompany pathological cardiac hypertrophy (Avkiran et al. 2008) . Therefore, PKD is well studied as a component of myofilament and nuclear signal transduction in cardiomyocytes. Recent studies in non-cardiac cells suggest that PKD is localized not only in the cytosol and nuclear compartment, but also in the mitochondria in response to cellular stress (Storz et al. 2005; Storz, 2007; Cowell et al. 2009 ). In cardiomyocytes, prominent translocation of PKD to perinuclear regions after G q PCR stimulation was observed by Bossuyt's group (Bossuyt et al. 2011; Nichols et al. 2014 ), but to date there are no reports confirming the existence and translocation of PKD in cardiac mitochondria and their effect on mitochondrial function in the heart.
Here, we report that PKD is capable of directly phosphorylating the mitochondrial fission protein DLP1 at the OMM, which causes mitochondrial fragmentation, ROS overproduction, and mPTP opening, followed by activation of apoptotic signalling in both H9c2 cardiac myoblasts and rat neonatal cardiomyocytes (NCMs). This report identifies a novel PKD-specific substrate in mitochondria. In addition, our findings uncover the functional effect of PKD on mitochondria under persistent G q PCR stimulation in cardiomyocytes.
Methods

Ethical approval
All animal experiments were performed in accordance with the Guidelines on Animal Experimentation of Thomas Jefferson University (TJU) and Rhode Island Hospital (RIH). The study protocol was approved by the Animal Care Committee of TJU and RIH. The investigation conformed to the Guidelines for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH).
Plasmids, antibodies and reagents
The following plasmids were used for the experiments: Mitochondrial matrix-targeted Discosoma sp. red fluorescent protein (mt-RFP) (Yoon et al. 2003; O-Uchi et al. 2013) , green fluorescence protein (GFP)-tagged wild type (WT) and dominant-negative DLP1 mutant (DLP1-K38A) (Yoon et al. 2003; O-Uchi et al. 2013) ; GFP-tagged constitutively active mutant of PKD1 (PKD-S738/742E: PKD-CA) and kinase-dead (dominant-negative) mutant of PKD1 (PKD1-K612W: PKD-DN) (kindly provided by Dr Klaus Pfizenmaier, University of Stuttgart, Germany) (Jhun et al. 2012) ; D kinase activity reporter DKAR (Kunkel et al. 2009 ); yellow fluorescence protein (YFP)-tagged PKD1 (YFP-PKD1) (Kunkel et al. 2009 ) and OMM-targeted C kinase activity reporter CKAR (OMM-CKAR) (Gallegos et al. 2006 ) (Addgene, Cambridge, MA, USA); human influenza haemagglutinin (HA)-tagged rat WT-DLP1 (HA-DLP1-WT) and mutant (HA-DLP1-S637A) (kindly provided by Dr Stefan Strack, University of Iowa, USA; Cribbs & Strack, 2007) ; YFP-tagged human WT-DLP1 J Physiol 596.5 and mutant (YFP-DLP1-S616A and YFP-DLP1-S637A) (kindly provided by Dr Luca Scorrano, University of Padua, Italy; Cereghetti et al. 2008) ; HA-tagged human α 1A -adrenoreceptor (α 1A -AR) in DoubleTrouble (pDT) (kindly provided by Dr John Hepler, Emory University School of Medicine, USA; Jhun et al. 2012) ; pEGFP-C1, pEGFP-N1, and pYFP-C1 (Clontech, Mountain View, CA, USA); and pcDNA3.1/hygro(+) (Invitrogen, Grand Island, NY, USA). OMM-targeted cyan fluorescent protein (mt-CFP) was generated from OMM-CKAR (Addgene) by deleting FHA2, substrate peptide, and YFP domains.
All chemicals and reagents were purchased from Sigma-Aldrich Corporation (St Louis, MO, USA) except for Protein A/G Plus Agarose, Mito-Tempo and cyclosporin A (CsA) (Santa Cruz Biotechnology, Santa Cruz, CA, USA), GST-PKD (Life Technologies, Carlsbad, CA, USA), prazosin hydrochloride (Tokyo Chemical Industry Co., Ltd, Tokyo Japan), ON-TARGET plus Rat PKD1 siRNA-SMART pool (Dharmacon, Lafayette, CO, USA), and PKD inhibitor CRT0066101 (Tocris, Minneapolis, MN, USA).
The following primary antibodies were used for Western blot analysis, immunoprecipitation, in vitro kinase assay, and immunocytochemistry: anti-PKD, α-tubulin, and anti-HA antibodies (Sigma-Aldrich); anti-
anti-voltage-dependent anion channel (VDAC), anticleaved-caspase-3, anti-GFP, and anti-Argonaute 2 (Argo2) antibodies (Cell Signaling, Danvers, MA, USA); anti-DLP1, anti-translocase of outer mitochondrial membrane 20 (TOM20), and anti-cytochrome C (BD Biosciences, San Jose, CA, USA); anti-GFP (mouse monoclonal) antibody (Roche, Mannheim, Germany and Cell Signaling).
Cell preparation, culture and transfection
H9c2 rat cardiac myoblasts (American Type Culture Collection, Manassas, VA, USA) and HEK293T cells (kindly provided by Dr Keigi Fujiwara, University of Texas MD Anderson Cancer Centre) were maintained in Dulbecco's modified Eagle's medium (DMEM) (Mediatech/Corning, Corning, NY, USA and Genesee Scientific, San Diego, CA, USA) supplemented with 4.5 g L −1 glucose, 1 mM sodium pyruvate and 1% L-glutamine, 10% fetal bovine serum (FBS) (GIBCO, Grand Island, NY, USA), 100 U ml −1 penicillin, 100 μg mL −1 streptomycin (Mediatech/Corning) at 37°C with 5% CO 2 in a humidified incubator (O-Uchi et al. 2014) . Cells were transfected with plasmids using FUGENE-HD transfection reagent (Promega, Madison, WI, USA) or with siRNA using Lipofectamine RNAiMAX (Invitrogen), re-plated 24 h after transfection using Accutase (Innovative Cell Technologies, San Diego, CA, USA) and used for experiments 48 h after transfection (Jhun et al. 2012; O-Uchi et al. 2013 O-Uchi et al. , 2014 . Two-to three-day-old Sprague-Dawley rats (Envigo, Huntingdon, UK and Taconic Biosciences, Cortlandt, NY, USA) were killed by decapitation for harvesting the hearts. NCMs were isolated from ventricles using collagenase type 2 (Worthington, Lakewood, NJ, USA), plated onto gelatin-coated dishes and maintained in DMEM supplemented with 4.5 g L −1 , 1 mM sodium pyruvate and 1% L-glutamine, 10% FBS (GIBCO), 100 U ml −1 penicillin, 100 μg mL −1 streptomycin (Mediatech/ Corning) at 37°C with 5% CO 2 in a humidified incubator (Jhun et al. 2012; O-Uchi et al. 2014) . NCMs were transfected using FUGENE-HD (Promega) 48 h after isolation and used for experiments after 48 h after transfection (Jhun et al. 2012; O-Uchi et al. 2014) .
H9c2 cells and NCMs were stimulated with 10 or 100 μM phenylephrine (Phe) for indicated times. In some experiments, cells were pre-incubated with prazosin (1 μM, 10 min), or CRT0066101 (CRT) (5 μM, 1 h) (Harikumar et al. 2010) prior to Phe stimulation. In cardiomyocytes, Phe (>10 μM) stimulates not only α 1 -ARs, but also β-ARs due to their high expression level (O-Uchi et al. 2014) . Therefore, a β-AR antagonist propranolol (1 μM) was added to the extracellular solution in NCM experiments (Jhun et al. 2012; O-Uchi et al. 2014) .
Live cell imaging and quantitative analyses of mitochondrial morphology
Transfected cells were re-plated on glass-bottomed dishes (MatTek, Ashland, MA, USA) 24 h before examination (O-Uchi et al. 2014) . For live-cell imaging, all culture medium was replaced by Tyrode solution (mM): NaCl, 136.9; KCl, 5.4; CaCl 2 , 1; MgCl 2 , 0.5; NaH 2 PO 4 , 0.33; HEPES, 5; glucose, 5, pH 7.40 adjusted with NaOH. Mitochondrial morphology in cells expressing mt-RFP was monitored using an FV1000 laser scanning confocal microscope (Olympus, Tokyo, Japan) and a Nikon TE2000 epifluorescence microscope equipped with 60× oil TIRF objective lens (Nikon, Tokyo Japan) and Retiga EXi camera (QImaging, Surrey, BC, Canada) at room temperature as previously described (O-Uchi et al. 2013) . Confocal images of mt-RFP were obtained through a 568/55-nm excitation (Ex) filter, a 600-nm dichroic mirror, and a 653/95-nm emission (Em) filter. For epifluorescence imaging, cells were captured with a motorized Z-Focus control and the single focused images were generated from the Z-stack images by picking the focused regions from each frame using NIS-Elements software (Nikon). Quantitative analyses of mitochondrial morphology were performed using previously described methods . Confocal images or focus images generated from Z-stack images were processed through a convolve filter of Image J software (NIH) to obtain isolated and equalized fluorescent pixels . After converting to masks, individual mitochondria were subjected to particle analyses to acquired values for form factor (FF: the reciprocal of circularity value) and aspect ratio (AR: major axis/minor axis). When a mitochondrion is a perfect circle, both parameters have a minimal value of 1. Higher values of AR and FF indicate elongated tubular mitochondria and increased mitochondrial length and complexity, respectively (Yu et al. 2006) . Since the values of FF and AR frequently change in a similar direction, we show only FF values in the majority of the figures.
Immunocytochemistry and quantitative analyses of protein colocalization
NCMs plated on glass-bottom dishes were fixed with 4.0 % paraformaldehyde (Thermo Fisher Scientific, Waltham, MA, USA) at 4°C for 10 min, permeabilized with saponin at room temperature for 10 min, blocked with 10% goat serum (Cell Signaling Technology) and incubated with primary antibodies against phospho-DLP1(S637) and an OMM protein TOM20 overnight, followed by incubation with fluorescent secondary antibodies (Thermo Fisher Scientific) for 1 h (Jhun et al. 2012) . Immunostained images of NCMs were acquired with a Nikon TE2000 at different Z-axis planes (0.5 μm step, total 21 images) and a single focused image was generated from the Z-stack images using NIS-Elements software (Nikon). Negative control experiments were performed using secondary antibodies without incubation of primary antibodies, which showed no noticeable labelling. Colocalization analysis and the generation of colour and frequency scatter plots were performed using Image J software (NIH) with an Intensity Correlation Analysis plug-in (The Bob and Joan Wright Cell Imaging Facility, Toronto Western Hospital) (O-Uchi et al. 2013 (O-Uchi et al. , 2014 . Colocalization of phospho-DLP1 (S637) and TOM20 was estimated using Pearson's correlation coefficient (O-Uchi et al. 2013) . The values for Pearson's correlation range from 1 to −1. A value of 1 represents perfect correlation, −1 represents perfect exclusion, and 0 represents random localization.
Visualization of OMM-bound PKD and quantification of PKD activity at the OMM in live cells PKD translocation to the specific subcellular compartments in live cells was assessed by Förster resonance energy transfer (FRET) between YFP-PKD and organelle-membrane targeted CFP (Kunkel et al. 2009) . Briefly, to determine PKD translocation to the OMM, H9c2 cells were co-transfected with YFP-PKD, mt-CFP, and α 1A -adrenoceptor receptor (α 1A -AR). Cells were stimulated with Phe at room temperature. CFP and FRET images were acquired every 10 s through a 420/20-nm Ex filter, a 450-nm dichroic mirror, and a 475/40-nm or 535/25-nm Em filter for CFP and FRET, respectively. YFP images were obtained as a control to evaluate photobleaching through a 495/10-nm Ex filter, a 505-nm dichroic mirror, and a 535/25-nm Em filter.
Measurement of mitochondrial superoxide (mSO) levels
To measure changes in mitochondrial superoxide (mSO) levels in live cells in response to Phe stimulation, the mSO-sensitive dye MitoSOX Red (Invitrogen) was used (Hom et al. 2010; O-Uchi et al. 2013 O-Uchi et al. , 2014 . Briefly, cells were incubated with MitoSOX Red in DMEM for 15 min and washed in phosphate-buffered saline. After washing, the culture medium was replaced by Tyrode solution containing 1 mM CaCl 2 . MitoSOX Red intensity was time-dependently measured from individual cells every 30 s before and during Phe stimulation using a Nikon TE2000 epifluorescence microscope with 40× objective (Nikon) and Retiga EXi camera (QImaging). MitoSOX Red intensity was normalized to the averaged value before Phe stimulation. For each experimental set, cells treated with vehicle (water or DMSO) were used as controls. For cells transfected with GFP-PKD-DN, cells transfected with pEGFP-C1 were used as control.
Live cell imaging of mitochondrial permeability transition pore (mPTP) opening
Time-dependent mPTP opening was assessed by measuring calcein fluorescence quenched by cobalt ion as described previously Scorrano et al. 1999; Yu et al. 2008) . H9c2 cells were loaded with 1.0 μM calcein-AM ester (Molecular Probes) and 1.0 mM CoCl 2 in Tyrode solution for 15 min at 37°C. Fluorescence images of mitochondria-localized calcein were acquired every 30 s before and after Phe stimulation at room temperature using laser scanning confocal microscopy with Fluoview software (Olympus). As a positive control, the ionophore ionomycin was used to trigger Ca 2+ -dependent mPTP activation. In some experiments, cells were pretreated with a PKD inhibitor, 5 μM CRT0066010 (CRT, PKD inhibitor) (Harikumar et al. 2010) , or 1 μM cyclosporine A (CsA, mPTP blocker as a negative control) and stimulated with Phe in the presence of these chemicals.
Electron microscopy (EM)
Mitochondrial morphology in NCMs was assessed via transmission electron microscopy (EM) as previously J Physiol 596.5 reported (O-Uchi et al. 2013) . NCMs were fixed in 2% glutaraldehyde in 0.1 M phosphate buffer, post-fixed in 1% osmium tetroxide in the same buffer, dehydrated in ethanol, and embedded in epoxy resin. Thin sections were stained with uranyl acetate and lead citrate. All specimens were viewed with a transmission EM (FEI Tecnai 12 transmission EM equipped with an XR111 megapixel charge-coupled device (Advanced Microscopy Techniques, Woburn, MA, USA). Mitochondria size, number, shape (FF), and grey value intensity in each mitochondrion area were assessed with Image J (NIH) (O-Uchi et al. 2013) . Mitochondrial Injury Index was calculated from EM images following previously described criteria (Joiner et al. 2012) : 0 = no detectable disruption in any mitochondria/ field, 1 = cristae disrupted in one mitochondrion/field, 2 = disruption in >1 mitochondrion/field, 3 = ࣙ1 and <50% ruptured mitochondria/field, 4 = ࣙ50% mitochondria ruptured/field.
Mitochondrial protein isolation and Western blot
Mitochondrial-enriched (mito) fractions were isolated as previously described (O-Uchi et al. 2013 (O-Uchi et al. , 2014 . Briefly, cells were washed with cold isolation buffer (320 mM sucrose, 1 mM EDTA, 10 mM Tris-HCl, pH 7.4 adjusted by KOH), scraped from the dishes and collected by centrifugation at 700 × g for 5 min at 4°C. The pellets were suspended with isolation buffer containing 1% protease inhibitor cocktail (Sigma) and phosphatase inhibitor cocktail (Roche, Mannheim, Germany) and homogenized with a Dounce homogenizer. The homogenates were centrifuged at 700 × g for 10 min at 4°C and the resulting supernatants were centrifuged at 17,000 × g for 15 min at 4°C. The supernatants were then collected as cytosolic protein-enriched fractions. The final pellets (mitochondrial-enriched fractions) were re-suspended in lysis buffer (Cell Signaling Technology) containing 1 mM phenylmethylsulfonyl fluoride (PMSF) and 1% protease inhibitor cocktail. Argo2 or VDAC were used as markers and loading controls for cytosolic-enriched (Cyto) (Sen & Blau, 2005) or Mito fraction (O-Uchi et al. 2013 (O-Uchi et al. , 2014 , respectively. Whole cell lysates (WCL) from cultured cells were prepared as described previously (Jhun et al. 2012; O-Uchi et al. 2013; 2014) . The concentration of proteins was determined by bicinchoninic acid assay (Thermo Fisher Scientific). WCL, Cyto, and Mito fractions were separated by SDS-PAGE, transferred to nitrocellulose membrane and incubated with primary antibodies, followed by incubating with fluorescence-conjugated secondary antibodies. Immunoreactive bands were visualized by Odyssey Infrared Imaging System (LI-COR Biotechnology, NE, USA) (Jhun et al. 2012; O-Uchi et al. 2013; 2014) and quantified by densitometry using Image J software (NIH). Ventricular tissue lysates from 10-week-old transgenic (TG) mice with cardiac-specific overexpression of constitutively active Gα q (Gα q -Q209L) (Mende et al. 1998; and wild-type (WT) littermate controls were prepared. Briefly, ventricular tissues were quickly ground using liquid nitrogen-cooled mortar and pestle, followed by the incubation with lysis buffer at 4°C for 30 min, and centrifugation at 20,000 x g for 15 min at 4°C. Supernatants were collected as whole cell lysates and subjected to SDS-PAGE and Western blot analysis.
Immunoprecipitation
Immunoprecipitation was performed as previously descried (Jhun et al. 2012) . Briefly, WCL (500 μg) were incubated with primary antibodies (1 μg) overnight at 4°C. Protein A/G Plus Agarose were added to the whole cell lysates for 2 h, followed by three washes with lysis buffer and subsequent subjected to Western blot analysis.
PKD in vitro kinase assay
Full-length WT-or mutant (S637A) DLP1 was purified by immunoprecipitation using anti-HA antibody from the lysates obtained from HEK293T cells overexpressing HA-tagged DLP1-WT and DLP1-S637A. Purified WTor mutant DLP1 proteins and 0.1 μg of recombinant GST-PKD were incubated in a reaction buffer composed of 4 mM Mops (pH 7.2), 4 mM MgCl 2 , 2 mM β-glycerophosphate, 1 mM EGTA, 0.4 mM EDTA, 50 μM DTT, and 100 μM ATP at 30°C for 60 min. The reaction was stopped with SDS-sample buffer, followed by SDS-PAGE and Western blotting. Phosphorylation of DLP1 was assessed with an anti-phospho-PKD substrate antibody.
Measurement of [ 3 H]inositol phosphate formation
Twelve-week-old Gαq -Q209L TG mice and WT littermate controls were anaesthetized by isoflurane for harvesting the hearts for phospholipase C (PLC) β activity measurements (Mende et al. 1998 , 0.5 EDTA, and 10 glucose. After labelling, LiCl was added to a final concentration of 10 mM for 30 min. Next, total inositol phosphates (IP) were extracted with 20 mM formic acid, separated by anion exchange chromatography (Dowex AG1-X8), and quantitated by liquid scintillation counting. Data are normalized to weight of tissues (mg protein) and expressed as counts min −1 mg −1 tissue.
PKC kinase activity assay
Freshly dissected left ventricular tissue pieces (30-40 mg) from 12-15 week-old Gαq -Q209L TG mice and WT littermate controls were homogenized with cold lysis buffer containing 20 mM MOPS, 50 mM β-glycerolphosphate, 50 mM sodium fluoride, 1 mM sodium orthovanadate, 5 mM EGTA, 2 mM EDTA, 1% NP40, 1 mM DTT, 1 mM benzamidine, 1 mM PMSF, 10 μg mL −1 leupeptin, and 10 μg mL −1 aprotinin. The activity of PKC activity in tissue lysates were measured by enzyme-linked immuno-absorbent assay (ELISA) kit (Abcam, Cambridge, MA, USA), which utilizes a specific synthetic peptide as a substrate for PKC and a primary antibody that recognizes the phosphorylated form of the substrate. This ELISA is able to measure the activity of all isoforms of PKC in the tissue lysate. Diluted tissue lysate samples and ATP were added to the microplate wells. PKC specific substrate pre-coated on the wells were phosphorylated by the PKC present in the tissue lysate sample in the presence of ATP. The phosphorylated substrate was labelled by primary antibody targeted to phospho-PKC substrates. Next, horseradish peroxidase (HRP)-conjugated secondary antibody was added, and the assay was developed with 3,3 ,5,5 -tetramethylbenzidine (TMB) substrate. Finally, the colour development was stopped with acid stop solution and the intensity of the colour was measured in a microplate reader at optical density (OD) of 450 nm. Experimental conditions including the dilution of the lysates and reaction time were titrated by using serial dilutions of purified active PKC as a positive control. Acquired data were normalized to the protein concentration (μg μL −1 ) and the relative kinase activity in TG heart compared to that in WT was calculated.
Mitochondrial respiration measurement
H9c2 cells were seeded onto 96-well plates at a cell density of 15,000 cells per well and cultured overnight. 1 h before measurement, cell media was switched to Seahorse Assay Media (Agilent Technologies, Santa Clara, CA, USA) containing the indicated concentrations of Phe or vehicle (water) and maintained for 1 h at 37°C. Oxygen consumption rate (OCR) was measured with an XFe96 Extracellular Flux analyser (Seahorse Bioscience, North Billerica, MA, USA). Oligomycin A, carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP), and a combination of rotenone and antimycin A were loaded into a Seahorse upper plate (Agilent Technologies) to obtain injected concentrations of 1 μM, 0.75 μM, 1 μM and 1 μM, respectively. Measurements were taken for three cycles following each injection. The acquired results were normalized to the amount of protein in the each well. In addition to basal and maximal cellular OCR, the following parameters were measured by the sequential addition of pharmacological agents showing above: ATP-linked respiration, proton leak respiration, maximum respiration capacity, and reserve respiration capacity. ATP-linked respiration was obtained by subtracting the OCR after oligomycin from baseline cellular OCR, and proton leak respiration was estimated by subtracting non-mitochondrial respiration (OCR after rotenone and antimycin A) from the ORC after oligomycin A. Maximal respiratory capacity is derived by subtracting non-mitochondrial respiration from the OCR after FCCP. The mitochondrial reserve capacity is calculated by subtracting basal respiration from maximal respiratory capacity.
Data and statistical analysis
All results in the figures are shown as means ± standard error (SE). Student's unpaired t test was performed for two data sets. For multiple comparisons, one-way ANOVA followed by a post hoc Tukey test or two-way ANOVA followed by a post hoc Student-Newman-Keuls test was performed. Statistical significance was set at a P value of <0.05.
Results α 1 -AR stimulation induces mitochondrial fragmentation in a fission-and PKD-dependent manner in rat neonatal cardiomyocytes (NCMs)
To explore whether G q PCR signalling regulates mitochondrial morphology in cardiomyocytes, we first examined the effect of the stimulation of α 1 -AR on mitochondrial morphology in NCMs expressing mitochondrial matrix-targeted red fluorescent protein, mt-RFP (Yoon et al. 2003; O-Uchi et al. 2013 O-Uchi et al. , 2014 . Before stimulation, mitochondria were mostly tubular, with a small number of fragmented mitochondria also present (Fig. 1A) . Stimulation with the α 1 -AR agonist, phenylephrine (Phe) (10 μM, 1 h), increased the population of small and fragmented mitochondria compared to before stimulation (Fig. 1A) . To quantitatively assess the changes in mitochondrial morphology, individual mitochondria were subjected to particle analyses to acquire values for form factor (FF: the reciprocal of circularity value) and aspect ratio (AR: major axis/minor axis). When a mitochondrion is a perfect circle, both parameters have a minimal value of 1. Higher values of AR and FF reflect more tubular mitochondria and increased mitochondrial length and complexity, respectively (Yu et al. 2006) . In general, the values of FF and AR change in a similar direction (Yu et al. 2006; O-Uchi et al. 2013) . Phe decreased both FF and AR values (see also Methods), indicating mitochondrial J Physiol 596.5 fragmentation by α 1 -AR stimulation (Fig. 1B) . In addition, the expression of dominant-negative DLP1 mutant (GTP hydrolysis-deficient form of DLP1: DLP1-K38A) (Yoon et al. 2003; O-Uchi et al. 2013 ) significantly inhibited Phe-induced mitochondrial fragmentation (Fig. 1B) . These results indicate that α 1 -AR-mediated mitochondrial fragmentation occurs in a fission-dependent manner via DLP1 in NCMs. We next tested whether PKD, one of the kinases located downstream of G q PCRs, is involved in the regulation of mitochondrial morphology in NCMs. First, we examined the effect of pharmacological inhibition of PKD on mitochondrial morphology. We used a novel small-molecule PKD-selective inhibitor, 5 μM CRT0066101 (CRT), because this concentration of CRT significantly inhibits PKD but not PKCs and CaMKII in situ (Harikumar et al. 2010) . NCMs were pretreated with 5 μM CRT and stimulated with Phe in the continuous presence of CRT. Pretreatment of CRT showed slight (but not significant -P = 0.09) mitochondrial elongation (indicated by a small increase in FF) compared to control ( Fig. 1C and D) . CRT-pretreated cells did not show significant mitochondrial fragmentation after Phe stimulation ( Fig. 1C and D) . To further confirm whether activation of PKD is required for increased mitochondrial fission under α 1 -AR stimulation, we next manipulated PKD activity in NCMs by overexpressing GFP-tagged dominant-negative PKD1 (PKD1-K612W termed PKD-DN), a catalytically inactive form of PKD1 that cannot undergo a intramolecular cis-autophosphorylation) or constitutively active PKD1 (PKD-S738/742E termed PKD-CA), a PKD1 mutant containing glutamic acid residues in place of the PKC phosphorylation sites at serine 744 and 748) (Jhun et al. 2012) (Fig. 1E ). NCMs overexpressing GFP-tagged 1 h) . B, summary data of A. Average form factor (FF) and aspect ratio (AR) were calculated from individual mitochondria images. n = 3000-6000 mitochondria from each group from 3 different isolations of NCMs. * P < 0.05; N.S., not significant. C, representative confocal images of mitochondrial morphology in NCMs expressing mt-RFP before and after Phe stimulation (10 μM, 1 h) in the presence or absence of PKD inhibitor CRT0066101 (CRT, 5 μM, 1 h). D, summary data of C. Average FF was calculated from individual mitochondria images (n = 5000-8000 mitochondria from each group from 3 different isolations of NCMs). * P < 0.05. N.S., not significant. E, summary data of FF from individual mitochondria images in NCMs co-expressing mt-RFP with GFP-tagged dominant-negative (PKD-DN) or constitutive-active PKD (PKD-CA. n = 3000-6000 mitochondria from each group from 3 different isolations of NCMs. Cells transfected with GFP were used as control. * P < 0.05. N.S., not significant. [Colour figure can be viewed at wileyonlinelibrary.com]
PKD-DN did not undergo mitochondrial fragmentation after Phe stimulation (Fig. 1E) . Conversely, cells overexpressing GFP-tagged PKD-CA showed significant mitochondrial fragmentation in the absence of Phe stimulation compared to those overexpressing GFP only (Fig. 1E) . Together, these results indicate that Phe-induced mitochondrial fragmentation is predominantly mediated via PKD activation in NCMs.
α 1 -AR-PKD signalling induces mitochondrial fragmentation via PKD-dependent phosphorylation of DLP1 at S637
We next investigated how PKD activation enhances the mitochondrial fission machinery in cardiomyocytes. Since a majority of PKD is localized at the cytosol under basal conditions, we examined whether cytosolic PKD is capable of translocating from the cytosol to the mitochondrial area after α 1 -AR stimulation. Therefore, we first observed PKD translocation from the cytosol to the OMM in response to α 1 -AR stimulation using FRET-based live cell imaging (Kunkel et al. 2009 et al. 2013, 2014) . We co-transfected PKD-YFP, mt-CFP and α 1A -AR in H9c2 cells, stimulated the cells with Phe at room temperature, and measured FRET signal every 10 s using laser scanning confocal microscopy. We observed significant PKD translocation to the OMM in response to α 1 -AR stimulation, shown as an increase in the yellow/cyan Em ratio ( Fig. 2C and D) . Next, we measured the changes in PKD activity in response to Phe stimulation at the cytosol as well as at the OMM, using non-targeted and OMM-targeted FRET-based PKD kinase activity reporter DKAR, respectively (Kunkel et al. 2009; Bossuyt et al. 2011) (Fig. 3A-D) . We prepared the cells transfected with DKAR or OMM-targeted DKAR (mt-DKAR) and α 1A -AR and stimulated these cells with Phe. In this system, elevation of the cyan/yellow Em ratio indicates increased PKD activity (Fig. 3C ) (Kunkel et al. 2009; Bossuyt et al. 2011) . Cytosolic PKD activation was increased faster than that in the OMM, but the PKD activity in both cellular components reached similar levels within 10 min.
To further examine the subcellular localization of PKD and its activity before and after α 1 -AR stimulation, we obtained fractionated cytosolic (Cyto) and mitochondria-enriched (Mito) proteins from NCMs. We found a small amount of PKD in the Mito fraction under basal conditions ( Fig. 4B and C) . Phe stimulation increased the amount of PKD in the Mito fraction, shown as a significant increase in the ratio of mitochondrial to cytosolic PKD (Fig. 4B and C) . Importantly, α 1 -AR stimulation markedly increased PKD activity (evaluated by the amount of phosphorylated PKD) in the Mito fraction ( Fig. 4B  and C) . These results suggest that α 1 -AR stimulation induces PKD translocation from the cytosol to the OMM and increases its activity in the OMM, which led us to hypothesize that PKD may regulate mitochondrial morphology via phosphorylation of the fission machinery system (such as DLP1) when it translocates to the OMM.
Phosphorylation-dependent regulation of DLP1 is an important mechanism for regulating mitochondrial morphology in non-cardiac cells (Chang & Blackstone, 2007; Cribbs & Strack, 2007; Taguchi et al. 2007 ; Cereghetti Han et al. 2008; Qi et al. 2011; Yu et al. 2011) . We tested whether PKD is capable of directly phosphorylating DLP1 upon α 1 -AR stimulation and whether this changes mitochondrial morphology. Based on the reported PKD consensus phosphorylation motif LXRXX(T * /S * ) and the phosphorylation prediction programs NetPhos 2.0 and Group-based Prediction System (see our recent publications: Jhun et al. 2012; O-Uchi et al. 2014) , we found only one potential PKD-specific phosphorylation site (S637) in human DLP1, located at the border of the variable domain (VD) and GTPase-effector domain (GED) and evolutionarily conserved among species (Fig. 5A) . We next performed in vitro kinase assays with full-length WT or non-phosphorylatable DLP1 mutant (S637A) purified from HEK293T cells (see Methods) and a recombinant GST-PKD. We found that recombinant PKD directly phosphorylated DLP1 at S637 in vitro ( Fig. 5B  and C) . Using an antibody against the phospho-peptide corresponding to residues surrounding S637 of DLP1 (see also Methods), we found that PKD-CA overexpression in H9c2 cells increases phosphorylation of both overexpressed and endogenous DLP1 at S637 (Fig. 6A-C) . In addition, α 1 -AR stimulation phosphorylated DLP1 at S637 time-dependently in H9c2 cells (Fig. 6D) , which was abolished by inhibition of endogenous PKD activity using either genetic manipulation (transfection of PKD1-siRNA) (Fig. 6E and F) or a pharmacological approach (CRT pretreatment) (Fig. 6G) . Together, these experiments revealed DLP1 as a novel PKD substrate and identified S637 as the PKD phosphorylation site.
PKD-dependent phosphorylation of DLP1 at S637 induces DLP1 association to the OMM
We next sought to determine whether PKD-mediated DLP1 phosphorylation at S637 under G q PCR stimulation modulates the subcellular distribution of DLP1. Endogenous (Fig. 7A ) and overexpressed WT-DLP1 (Fig. 7B ) translocated to the Mito fraction after α 1 -AR stimulation in H9c2 cells. Overexpressed DLP1-K38A was found in the Cyto and Mito fractions at basal and also translocated to the Mito fraction upon Phe treatment (Fig. 7A-D) . This results indicate that DLP1 translocation to the mitochondria after Phe stimulation does not depend on its GTPase activity. Overexpressed DLP1-S637A in the Mito fraction was lower than WT-DLP1 at basal, and translocation to the Mito fraction after Phe stimulation was not detected (Fig. 7B-D) . These results suggest that phosphorylation of DLP1 at S637 has a critical role in G q PCR signalling-mediated DLP1 translocation to the mitochondria, but GTPase activity of DLP1 may not be involved. The effect of α 1 -AR stimulation could be mimicked by overexpression of PKD-CA, which induced DLP1 translocation to the Mito fraction ( Fig. 7C and D) . These findings suggest that DLP1 may be phosphorylated by activated PKD at the OMM or at the cytosolic region proximal to the OMM, which may then change its binding affinity to the OMM. DLP1-S616 is proposed as a phosphorylation site for cyclin-dependent kinase 1 (CDK1), extracellular signal-regulated kinases 1/2 (Erk1/2), PKCδ, and Ca 2+ /calmodulin-dependent kinase II (CaMKII) that changes DLP1 subcellular localization and mitochondrial morphology (Taguchi et al. 2007; Qi et al. 2011; Yu et al. 2011; Xu et al. 2016) . Since Erk1/2, CaMKII, or PKCδ is also activated by G q PCR stimulation, we next assessed whether S616 site is phosphorylated after G q PCR stimulation in addition to S637. We transfected WT or non-phosphorylatable DLP1 mutants (S616A and S637A) in H9c2 cells and detected the phosphorylation levels at S616 before and after Phe stimulation by Western blot using an antibody against the phospho-peptide corresponding to residues surrounding S616 of DLP1. We found that α 1 -AR stimulation did not change the phosphorylation state of DLP1 at S616 (Fig. 8A and B) , suggesting that only DLP1 phosphorylation at S637 occurs after G q PCR, and that therefore the phosphorylation state of S616 is likely not a major determinant for regulating mitochondrial morphology in our system. Importantly, DLP1-S637A mutant showed similar level of basal DLP1 phosphorylation at S616 compared to WT, and this phosphorylation was significantly decreased after α 1 -AR stimulation ( Fig. 8A and B) .
We next tested whether DLP1 phosphorylation at S637 by α 1 -AR-PKD signalling changes mitochondrial morphology in H9c2 cells. Cells expressing YFP underwent mitochondrial fragmentation after Phe stimulation ( Fig. 8C and D) , while cells overexpressing YFP-DLP1-S637A did not show significant Phe-mediated mitochondrial fragmentation ( Fig. 8C and D) . In addition, we also tested the effect of YFP-DLP1-S616A overexpression on mitochondrial morphology with or without α 1 -AR stimulation. Importantly, YFP-DLP1-S616A overexpression itself promoted significant mitochondrial fragmentation compared to the cells expressing YFP (Fig. 8C and D) . Moreover, Phe stimulation did not induce further changes in mitochondrial morphology in cells overexpressing YFP-DLP1-S616A (Fig. 8C and D) . These results suggest that (1) the increased levels of DLP1 phosphorylation at S637 (but not at S616) are critical in mitochondrial fragmentation after G q PCR stimulation, and (2) the DLP1-S637A mutation effect dominates over the dephosphorylation effect of S616 under G q PCR stimulation.
Since the S637 site was initially reported as a protein kinase A (PKA)-specific site in non-cardiac cells (Chang & Blackstone, 2007) , we also tested whether PKA signalling is able to phosphorylate DLP1 at S637 and modulate mitochondrial morphology in our system. We used the β-adrenoceptor (β-AR) agonist isoproterenol (Iso) and a cAMP-activator forskolin (Forsk) to activate PKA signalling in H9c2 cells. Indeed, both Iso and Forsk significantly increased DLP1 phosphorylation at S637 and DLP1 translocation to mitochondria (Fig. 9A and B) . However, Iso stimulation (10 μM, 1 h) did not induce any significant changes in mitochondrial morphology (Fig. 9C-E ) in our system, even though PKA signalling is significantly activated (Fig. 9F and G) . We also confirmed that other G q PCR stimulations (ET A receptor stimulation by endothelin 1 and H 1 receptor stimulation by histamine; O-Uchi et al. 2014; Gomez et al. 2016) were able to induce significant mitochondrial fragmentation in H9c2 cells ( Fig. 10A and B) . Moreover, we also found that endothelin 1 stimulation shows DLP1 translocation to mitochondria similar to the level of that in Phe stimulation ( Fig. 10C  and D) .
PKD-dependent phosphorylation of DLP1 at S637 induces DLP1 translocation to mitochondria and promotes mitochondrial fragmentation in rat neonatal cardiomyocytes (NCMs)
We next tested whether DLP1 phosphorylation at S637 by α 1 -AR-PKD signalling modulates DLP1 subcellular distribution and mitochondrial morphology in primary cardiomyocytes (Fig. 11) . First, we confirmed that α 1 -AR stimulation activates PKD and phosphorylated DLP1 at S637 in NCMs, which was abolished by PKD1 knockdown using PKD1-siRNA ( Fig. 11A and B 
-AR stimulation in H9c2 cells
A-C, DLP1 phosphorylation at S637 by PKD overexpression in H9c2 cells. A, HA-tagged DLP1-WT or mutant DLP1-S637A were co-transfected with GFP-PKD-CA. Overexpressed HA-DLP1s (upper bands) were immunoprecipitated by anti-HA antibody and the levels of DLP1 phosphorylation were assessed by anti-phospho-PKD substrate and anti-phospho-DLP1 (S637) antibodies. Representative blot images from 3 independent experiments are shown. B, cells were transfected with GFP-PKD-CA. Endogenous DLP1 was immunoprecipitated by anti-DLP1 antibody and the levels of DLP1 phosphorylation were assessed by anti-phospho-DLP1 (S637) antibody. C, summary data of B. n = 3 for each group. * P < 0.05. D, time-dependent activation of PKD and DLP1 phosphorylation at S637 by 10 μM Phe. Representative blot images from 4 independent experiments. E, effect of PKD knockdown on Phe-induce DLP1 phosphorylation. Cells transfected either with non-targeted (scramble, control) or PKD1-targeting siRNA were stimulated with Phe (10 μM, 30 min). F, summary data of E. n = 3 for each group. * P < 0.05. N.S., not significant. G, effect of PKD inhibition by CRT0066101 on Phe-induce DLP1 phosphorylation. Cells pretreated with DMSO (control) or CRT0066101 (5 μM, 1 h) were stimulated with Phe (10 μM, 30 min). n = 3 for each group. 
-AR-PKD-dependent phosphorylation of DLP1 regulates its subcellular distribution in H9C2 cells
A, translocation of endogenous DLP1 (lower bands) and exogenous GFP-DLP1-K38A (upper bands) to the Mito fraction after α 1 -AR stimulation in H9c2 cells. Cells were transfected with GFP (control) or GFP-DLP1-K38A and stimulated with Phe (10 μM, 1 h) followed by fractionation and Western blot using anti-DLP1 antibody. B, translocation of DLP1 WT and mutant (S637A) to the Mito fraction after α 1 -AR stimulation in H9c2 cells. Cells were transfected with HA-tagged DLP1-WT or -S637A and stimulated with Phe (10 μM, 1 h) followed by protein fractionation and Western blot using anti-HA antibody. C, PKD-mediated DLP1 translocation to the Mito fraction in H9c2 cells. Cells were transfected with GFP (control) or GFP-PKD-CA followed by protein fractionation and Western blot using anti-DLP1 antibody. D, summary of data of DLP1 (WT, K38A, or S637A) translocation by either Phe stimulation or PKD-CA overexpression in H9c2 cells. n = 4 for each group. * P < 0.05. N.S., not significant.
and after Phe stimulation (see also Fig. 4) . We found that a small amount of DLP1 was translocated from the cytosol to the mitochondria by α 1 -AR stimulation, as evidenced by a significant increase in the ratio of mitochondrial DLP1 to cytosolic DLP1 after Phe stimulation ( Fig. 11C  and D) . Importantly, pharmacological inhibition of PKD by CRT abolished Phe-mediated DLP1 translocation to the mitochondria ( Fig. 11C and D) . DLP1 phosphorylation and DLP1 translocation were further assessed by immunocytochemistry ( Fig. 11E-G) . We found that Phe treatment significantly increases the cellular fluorescent intensity value of anti-P-DLP1-S637 immunostaining (Fig. 11G , left panel) as well as the colocalization coefficient value of the immunostaining of OMM protein TOM20 and P-DLP1-S637 (Fig. 11G, right panel) , indicating that the amount of phosphorylated DLP1 increases at the mitochondria after α 1 -AR-PKD signalling activation in NCMs, which was completely abolished by the presence of the pharmacological inhibition of PKD by CRT. Finally, we tested whether DLP1 phosphorylation induced by α 1 -AR-PKD signalling promotes mitochondrial fragmentation in live NCMs transfected with mt-RFP ( Fig. 11H and I) . NCMs overexpressing GFP underwent mitochondrial fragmentation after Phe stimulation, but overexpression of GFP-DLP1-S637A significantly inhibited α 1 -AR-mediated mitochondrial fragmentation. These results suggest that DLP1 phosphorylation at S637 induced by enhanced α 1 -AR-PKD signalling is critical for DLP1 translocation to the mitochondria as well as mitochondrial fragmentation in NCMs. Our data indicate that cardiac α 1 -AR signalling can regulate mitochondrial morphology in NCMs (Fig. 1) . Specifically, we show that α 1 -AR stimulation induces PKD-dependent phosphorylation of DLP1 at S637, which initiates DLP1 translocation to the OMM (Figs 7, 8, and 11) . Importantly, we found that Phe-induced mitochondrial fragmentation was abolished by GFP-DLP1-S637A expression in NCMs, indicating that the S637 site has a critical role in G q PCR signalling-mediated mitochondrial fragmentation in NCMs ( Fig. 11H and I) . Since the mitochondria fragmented by the enhanced fission process increases ROS generation in non-cardiac cells (Yu et al. 2006 (Yu et al. , 2011 Madesh et al. 2009; Gan et al. 2014) , we next hypothesized that fragmented mitochondria under G q PCR signalling increase ROS. We tested whether α 1 -AR-PKD signalling increases mitochondrial superoxide (mSO) by staining H9c2 cells with the mSO-sensitive dye, MitoSOX-Red (O-Uchi et al. 2013 , 2014 (Fig. 12) . First, we confirmed that Phe treatment significantly increased mSO levels compared to that of vehicle treatment, Figure 9 . β-AR-PKA signalling phosphorylates DLP1 at S637 and translocates DLP1 to mitochondria, but does not change mitochondrial morphology in H9c2 cells A, left: DLP1 phosphorylation at S637 by 10 μM Phe, 10 μM Iso, 10 μM Forsk. H9C2c cells were stimulated by each drug for 30 min. Endogenous DLP1 was immunoprecipitated using anti-DLP1 antibody and the phosphorylation levels of DLP1 at S637 were assessed by anti-phospho-DLP1 (P-DLP1) (S637) antibody. Representative blot images from 4 independent experiments are shown. Right: DLP1 translocation after 1-h Phe, Iso and Forsk stimulation observed in cytosolic (Cyto) and mitochondrial-enriched (Mito) fractions obtained from H9C2 cells. Cytosolic protein Argo2 or mitochondrial protein VDAC was used as a marker for confirming the purity of the fractionated proteins. Representative blot images from 4 independent experiments are shown. B, summary data of A. n = 4 for each group * P < 0.05, compared to control. C, representative images of mitochondrial morphology before (control, CTR) and after 10 μM Phe or 1 μM Iso stimulation for 1 h in H9c2 cells expressing mtRFP observed by epifluorescent microscopy. D, comparison of AR and FF of individual mitochondria calculated from representative images of mitochondria in Phe-or Iso-treated cells against that in CTR. E, summary of average FF and AR. * P < 0.05, compared to CTR. F, PKA and PKD signalling activation by 10 μM Phe, 10 μM Iso, and 10 μM Forsk. H9c2 cells were stimulated by each drug for 10 min. PKA and PKD signalling activation were assessed using anti-phospho-PKA substrate and anti-phospho-PKD substrate antibodies, respectively. Note that the anti-phospho-PKA substrate antibody is capable of cross-reacting with a general PKD-substrate motif, but less likely to detect the PKA motif (see red underlines). G, summary data of F. n = 4 for each group. * P < 0.05, compared to CTR. [Colour figure can be viewed at wileyonlinelibrary.com] and this effect was abolished by pretreatment with the α 1 -AR antagonist prazosin, and a mitochondria-targeted antioxidant Mito-Tempo, as we previously reported (O-Uchi et al. 2014) (Fig. 12A and B) . Importantly, pharmacological as well as genetic inhibition of PKD activity (by PKD inhibitor CRT and GFP-tagged PKD-DN overexpression, respectively) significantly inhibited the Phe-induced mSO increase (Fig. 12C-E) . These results indicate that G q PCR signalling promotes mitochondrial ROS (mROS) generation via PKD activation. Since chronic and excessive mSO increases the susceptibility to mPTP opening which causes subsequent cell injury and death (Halestrap, 2009) , we next assessed mPTP opening in response to G q PCR stimulation ( Fig. 12F and G) . α 1 -AR stimulation induced a small but significant loss of mitochondrial calcein fluorescence compared to that in vehicle-treated cells, which was completely blocked by pretreatment with either the mPTP blocker CsA, or the PKD inhibitor CRT (Fig. 12F  and G) . However, Phe-mediated calcein fluorescence loss was significantly smaller than that observed under ionomycin (Ion) treatment (estimated as the condition in which mPTP is fully opened). Time-dependent proapoptotic protein release by Phe stimulation was also confirmed by detection of cytochrome C in the Cyto and Mito fractions (Fig. 12H) , consistent with the results of partial mPTP opening detected by the calcein quenching experiments (see Fig. 12F and G) .
To determine whether mSO production induced by α 1 -AR-PKD signalling activation triggers mPTP opening, or whether α 1 -AR-PKD-DLP1 signalling directly triggers mPTP opening, which secondarily causes mSO production after mPTP opening, we monitored changes in mSO levels after Phe stimulation in the presence of CsA (Fig. 12I) . Inhibition of mPTP activity by CsA (Fig. 12F ) failed to prevent an mSO increase in the cells during α 1 -AR stimulation, indicating that α 1 -AR-PKD-induced mROS production is upstream of mPTP opening. Finally, . PKD activation induces DLP1 phosphorylation at S637, DLP1 translocation to mitochondria, and mitochondrial fragmentation during α 1 -AR stimulation in NCMs A, effect of PKD knockdown on Phe-induced DLP1 phosphorylation. NCMs transfected either with non-targeted (scramble, control) or PKD1-targeting siRNA were stimulated with Phe (10 μM, 30 min) in the presence of 1 μM propranolol. B, summary data of A. n = 3 for each group. * P < 0.05; N.S., not significant. C, DLP1 translocation after Phe stimulation (10 μM, 1 h) detected from cytosolic (including SR/ER) (Cyto) and mitochondrial-enriched (Mito) fractions obtained from NCMs pretreated with or without PKD inhibitor CRT. SR protein SERCA or mitochondrial protein VDAC were used as markers to confirm the purity of the fractionated proteins. D, summary data of C. DLP1 translocation was calculated as the ratio of mitochondrial to cytosolic DLP1 (Mito-DLP1/Cyto-DLP1). N = 4 for each group. * P < 0.05, compared to control (untreated cells). E, immunofluorescence images of fixed NCMs labelled with antibodies against P-DLP1 (S637) (green) and the mitochondrial marker TOM20 (red) before (top) and after Phe stimulation (10 μM, 1 h) (middle). The cells stimulated with Phe in the presence of 5 μM CRT is also shown (bottom). F, frequency and colour scatter plots generated from the images in E. G, summary data of averaged P-DLP1 (S637) fluorescent intensity (left) and Pearson's correlation coefficient value in NCMs. * P < 0.05, compared to control (DMSO). n = 23-35 for each group. H, inhibition of α 1 -AR-mediated mitochondrial fragmentation by overexpression of DLP1-S637A in NCMs. NCMs were co-transfected with mt-RFP and GFP (control) or GFP-tagged DLP1-S637A and stimulated by Phe (10 μM, 1 h). Representative fluorescent images are shown with convolve images of mt-RFP. I, summary data of H. Average FF values were calculated from confocal images of live NCMs using the procedure described in Methods. n = 2000-4500 mitochondria from each group from 3 different isolations of NCMs. * P < 0.05. N.S., not significant. [Colour figure can be viewed at wileyonlinelibrary.com]
an α 1 -AR stimulation-induced increase in the amount of cleaved-caspase 3 was also detected (Fig. 12J) .
To determine whether mPTP activation upon G q PCR stimulation also occurs in native cardiomyocytes, we examined ultrastructual changes in cardiac mitochondria after Phe stimulation in NCMs using transmitted EM. After 1-h Phe stimulation, the number of small and rounded mitochondria with intact structural integrity increased (Fig. 13A , left and middle), reflected by a decrease in the average mitochondrion size and FF (Fig. 13B-D) , consistent with the results of confocal microscopy (see Fig. 1 ). Interestingly, Phe-treated cells included a subpopulation (2nd peak of size histogram in Fig. 13B ) of swollen mitochondria with disrupted cristae structures (Fig. 13A, right) , shown as a decrease in averaged grey-value in mitochondrial area ( Fig. 13E ) and an increase in averaged mitochondrial injury index (Joiner et al. 2012) (Fig. 13F) . Taken together, these observations suggest that G q PCR signalling induces mitochondrial ROS production and partial mPTP activation, which initiates the activation of apoptotic signalling. To further explore the mechanism of α 1 -AR-PKD signalling-mediated mROS increase, we measured oxygen consumption in H9c2 cells with or without Phe stimulation (Fig. 14) . Oxygen consumption profiles indicated that Phe exposure concentration-dependently accelerated respiration (Fig. 14A) . We found that both basal and maximal cellular OCR, ATP-linked respiration, reserve respiration capacity, and maximal respiration capacity after Phe stimulation (100 μM, 1 h) were significantly elevated compared to those in non-stimulated cells (Fig. 14B and C) . In addition, these changes in OCR were completely abolished in the presence of CRT, indicating that acceleration of mitochondrial respiration is mediated via PKD activation (Fig. 14B and C) .
G q PCR stimulation increases PKD activation and DLP1 phosphorylation in vivo
To substantiate our in situ observations in an in vivo setting, we examined whether apoptotic signalling can be activated via the G q PCR-PKD-DLP1 cascade in vivo, using ventricular samples from TG mice with cardiac-specific transient expression of constitutively active Gα q protein (Gα q -Q209L) (Mende et al. 1998) . The Gα q -Q209L TG mouse lines exhibit (1) chronic activation of G q PCR signalling; (2) time-dependent activation of PKC isoforms (Mende et al. 1999 (Mende et al. , 2001 ; (3) time-dependent progression of HF via cardiac hypertrophy, and dilatation (Mende et al. 1998 (Mende et al. , 2001 ; and (4) mitochondrial injury (fragmentation and swelling) (Elas et al. 2008; Czarnowska et al. 2016) . We found that PKD activity, DLP1 phosphorylation at S637, and caspase-3 activity are significantly elevated in ventricular tissues from 10-week-old TG mouse hearts compared to those from WT (Fig. 15A, B and D) . We also assessed PKC activity and DLP1 phosphorylation at S616 in these heart samples. To measure total PKC activity from all PKC isoforms, we performed Western blot analysis using anti-phospho-PKC substrate antibody and ELISA assay. However, we did not find significant increase in PKC activity in TG ventricular tissues compared to WT (Fig. 15C-E) , although basal PLC activity continued to be elevated in TG heart tissues (Fig. 15F) . The levels of DLP1 phosphorylation at S616 significantly increased in TG mice samples (Fig. 15A-D) , suggesting that phosphorylation of S616 in DLP1 may not be mediated via PKC, but potentially by other kinase(s), under chronic G q PCR stimulation in vivo. In summary, these data show that G q PCR-PKD-dependent DLP1 phosphorylation at S637 occur in vivo and likely contribute to mitochondrial injury and apoptotic signalling activation.
Discussion
In this study, we investigated the role of PKD in cardiac mitochondrial morphology and function, focusing on the molecular mechanisms underlying PKD-dependent regulation of DLP1 function through its phosphorylation. In summary, we found that: (1) PKD activated by G q -coupled α 1 -AR translocates to the OMM; (2) activated PKD at the OMM phosphorylates DLP1 at the OMM or at the cytosolic region in the proximity of OMM; (3) PKD-dependent phosphorylation of DLP1 at S637 increases DLP1 binding affinity to the OMM; (4) greater DLP1 association with the OMM promotes increased mitochondrial fragmentation, possibly by forming a ring around the OMM through DLP1 oligomerization, thus enhancing the mechanical force for fission (Detmer & Chan, 2007; Liesa et al. 2009; Archer, 2014) ; (5) mitochondrial fragmentation enhances mitochondrial ROS generation and mPTP activity; and (6) the partial opening of mPTP initiates the activation of apoptotic signalling. These morphological and functional changes in cardiac mitochondria can be reversed by inhibiting PKD-dependent phosphorylation DLP1 at S637. Our data may uncover the detailed molecular mechanisms underlying G q PCR-mediated pro-apoptotic pathways, and provide a pivotal role for PKD signalling in the regulation of mitochondrial morphology and function in cardiomyocytes.
PKD translocation and its function in cardiac mitochondria
In this study, we found that (1) a small amount of PKD exists endogenously in mitochondria-enriched fractions (Fig. 4B) , (2) overexpressed PKD1 is localized both in te cytosol and in mitochondria (Fig. 7C) and (3) fluorescently tagged PKD1 translocates to the OMM upon Phe stimulation ( Fig. 2C and D) , indicating at least that PKD1 can reside in mitochondria under basal conditions and cytosolic PKD1 is able to translocate to the mitochondria in response to G q PCR stimulation. In addition, we showed that PKD1 knockdown significantly decreases DLP1 phosphorylation levels, which possibly occurs at or near the OMM (Figs 6E and 11A) . These results also indicate that the majority of PKD activity in the OMM is due to PKD1 in our preparations. Interestingly, all three PKD isoforms contain predicted N-terminal mitochondria-targeted sequences (MTS) as assessed by MitoProt (Claros & Vincens, 1996) , but show a small probability of mitochondria localization (MitoProt scores of 0.1581, 0.0209, and 0.7652, respectively, where 1.0000 indicates protein localization exclusively in the mitochondria) and are not listed in the large scale inventory of mammalian mitochondria-localized proteins such as MitoCarta (Calvo et al. 2016) . Therefore, our experimental findings demonstrated the existence of PKD1 signalling in cardiac mitochondria for the first time.
We also identify the spatial and temporal profiles of PKD translocation to the OMM and the changes in PKD activity in the OMM upon G q PCR stimulation (Figs 2  and 3 ). PKD translocation to the OMM starts immediately after Phe stimulation, similar to PKD translocation to the plasma membrane (PM) (Kunkel et al. 2009 ). The molecular mechanism for rapid PKD translocation to the PM in response to G q PCR stimulation is well studied: a cysteine-rich domain in the N-terminus of PKD is required for binding to diacylglycerol at the PM (Rey et al. 2001) . Interestingly, diacylglycerol also exists in the mitochondrial membranes and activates PKD1 in mitochondria in Hela cells (Cowell et al. 2009 ). Therefore, it is reasonable to speculate that PKD may translocate to the OMM in cardiomyocytes via association with a subcellular pool of diacylglycerol different from that in the PM. Further studies are needed to elucidate whether cardiac mitochondrial OMM contains diacylglycerol and can serve as a binding partner for anchoring PKD to the OMM in cardiomyocytes.
Using both recombinant proteins (Fig. 5 ) and cell studies (Figs 6 and 11) , we also identified the mitochondrial fission protein DLP1 as a novel and direct substrate of PKD. Using FRET-based PKD translocation assay, we found that PKD gradually accumulates at the OMM during Phe stimulation, and the amount of PKD at the OMM does not decrease during the measurement period (up to 30 min). This result suggests that (1) PKD activates DLP1 mostly when it is at the OMM; and (2) the majority of PKD may not have access to the interior of mitochondria (i.e. the intermembrane space, IMM and mitochondrial matrix), and remain instead at the OMM. However, we cannot completely exclude the possibility that PKD penetrates the OMM and translocates to the inside of mitochondria, which may change the electron transport chain (ETC) activity as well as mPTP activity via phosphorylation of other mitochondrial proteins located inside the mitochondria, similar to PKC, which accesses the matrix upon activation (Mochly-Rosen et al. 2012) . Additional experiments will be required to characterize PKD distribution inside the mitochondria in addition to the surface of mitochondria (i.e. OMM) before and after G q PCR stimulation.
Phosphorylation of DLP1 by PKD1 and its role in regulating mitochondrial morphology
In this study, using NCMs and H9c2 cardiac myoblasts, we show PKD-mediated phosphorylation of DLP1 as a key mechanism for DLP1 translocation to the OMM upon G q PCR stimulation (Fig. 7) . Moreover, biochemical observations (increased PKD activity and DLP1 phosphorylation at S637) in the heart tissues from Gα q -Q209L TG mouse lines (Fig. 15 ) also fit with our idea that PKD-mediated DLP1 phosphorylation occurs in vivo.
The following DLP1 phosphorylation sites have been previously reported to possibly change the DLP1 subcellular localization. (1) S616 is located within a consensus TG  WT  TG  WT  TG  WT  TG  WT  TG  WT  TG  WT   TG  WT   TG  WT  TG  WT  TG  WT  TG Figure 15 . PKD activity, DLP1 phosphorylation and apoptotic signalling increase in ventricular tissues from transgenic mice with cardiac-specific overexpression of constitutively active Gα q (Gα q -Q209L) A, PKD activity, DLP1 phosphorylation and caspase-3 activity in ventricular tissues from 10-week old Gα q -Q209L TG and control (WT) mice. PKD activation was assessed by anti-phospho-S744/748 antibody and the levels of DLP1 phosphorylation were assessed by anti-phospho-DLP1 (S616) and (S637) antibodies. Caspase 3 activity was assessed by anti-cleaved caspase 3 antibody. B, PKD activity in Gα q -Q209L TG and control (WT) mice were assessed using anti-phospho-PKD substrate antibody. C, PKC activity in Gα q -Q209L TG and control (WT) mice were assessed using anti-phospho-PKC substrate antibody. D, summary data of A, B and C (n = 6 for each group). * P < 0.05; N.S., not significant. E, PKC kinase activity in left ventricular tissues from 12-to 14-week-old Gα q -Q209L TG (n = 9) and WT mice (n = 6) assessed by ELISA. N.S., not significant. F, basal PLC activity in the hearts of 12-week-old Gα q -Q209L TG (n = 6) and WT mice (n = 3). PLC activity was determined in the tissue pieces from left atria (LA), right atria (RA), and right ventricles (RV). * P < 0.05. [Colour figure can be viewed at wileyonlinelibrary.com] J Physiol 596.5 motif for CDK1 (Taguchi et al. 2007 ) and Erk1/2 (Yu et al. 2011) . It is also shown that CaMKII and PKCδ are capable of phosphorylating S616, although the sequence around this site is not a common motif for these kinases (Qi et al. 2011; Xu et al. 2016) . (2) S637 is shown as a site for PKA, Ca 2+ /calmodulin-dependent protein kinase I (CaMKI) and calcineurin (Chang & Blackstone, 2007; Cribbs & Strack, 2007; Cereghetti et al. 2008; Han et al. 2008) . (3) S693 is a glycogen synthase kinase 3β (GSK3β)-specific site (Chou et al. 2012) .
Our results show that PKD-mediated phosphorylation at S637 under G q PCR stimulation promoted mitochondrial fragmentation using a S637A mutant (Figs 8C and D and 11H and I) . Our result is consistent with the results of CaMKI-dependent DLP1 phosphorylation in non-cardiac cells reported by Matsushita's group (Han et al. 2008) , although the majority of other groups reported opposite effects (i.e. S637 phosphorylation inhibits fission or S637 dephosphorylation promotes fission) (Chang & Blackstone, 2007; Cribbs & Strack, 2007; Cereghetti et al. 2008) . Indeed, the functional consequence of S637 phosphorylation for the regulation of mitochondrial morphology is still highly controversial. Most prior studies selected the strategy of overexpressing the phospho-or dephospho-mimetic mutants of DLP1 (S637D and S637A, respectively); S637D overexpression induces mitochondrial elongation (Chang & Blackstone, 2007; Cribbs & Strack, 2007; Cereghetti et al. 2008) , or fragmentation (Han et al. 2008) ; and S637A overexpression induces mitochondrial fragmentation (Cribbs & Strack, 2007; Cereghetti et al. 2008) , elongation (Han et al. 2008) , or no significant changes in mitochondrial morphology (Chang & Blackstone, 2007) . In part, the different functional effects of DLP1-S637 phosphorylation observed in prior studies may be due to the different cell types used for the overexpression of DLP1 mutants. In most prior studies, Hela cells and fibroblasts were used. These cell lines possess distinct basal mitochondrial shape/network (i.e. highly elongated and interconnected) compared to H9c2 cells and NCMs which have a mixture of small and tubular mitochondria in the resting condition (see Figs 1 and 8-11 ). Another possible explanation for this discrepancy could be the involvement of different upstream molecules such as PKA (Chang & Blackstone, 2007) , CaMKI (Han et al. 2008) or calcineurin (Li et al. 2016) , which are generally not located downstream of PKD. Indeed, we also assessed PKA-mediated changes in mitochondrial morphology and found that PKA activation by β-AR stimulation increased DLP1 phosphorylation at S637 similar to the level of that after α-AR stimulation, consistent with previous results using the PKA activator Forsk (Chang & Blackstone, 2007; Khacho et al. 2014) . Moreover, we found that β-AR-mediated PKA activation promotes DLP1 translocation to mitochondria (Fig. 9A ) in H9c2 cells, similar to the case of α-AR-mediated PKD activation. However, we were unable to find any significant changes in mitochondrial morphology after β-AR stimulation (Fig. 9C) . The discrepancy between the effect of PKA and PKD on mitochondrial morphology in our system may be due to the involvement of multiple molecular mechanisms simultaneously elicited by cell signalling manipulation. For instance, phosphorylation at one site may prevent or initiate phosphorylation or dephosphorylation at the other sites by changing the access of other kinases or the phosphatases. Since the amount of DLP1 at the OMM increases both in β-AR and G q PCR stimulation, it is conceivable that (1) β-AR signalling indirectly changes the phosphorylation state of other sites, which decreases GTPase activity, thus cancelling the effect of an increased amount of DLP1 at the OMM and inhibiting mitochondrial fission; or (2) G q PCR signalling indirectly changes the phosphorylation state of other sites, which increases GTPase activity, thus accelerating the effect of increased DLP1 amount at the OMM and promoting mitochondrial fission.
We also assessed the role of S616 site in our system under α-AR stimulation (Fig. 8) . Although acute G q PCR stimulation significantly activates PKC and CaMKII (O-Uchi et al. 2008) , the increased S616 phosphorylation after Phe stimulation was not detectable (Fig. 8A  and B) , indicating that S616 may not be a direct PKCδ or CaMKII phosphorylation site under G q PCR stimulation. In addition, we found that DLP1-S616A overexpression itself promotes mitochondrial fragmentation ( Fig. 8C  and D) , indicating that the increased phosphorylation of S616 alone is not likely to induce significant DLP1 translocation to the OMM. However, it is still possible that the phosphorylation state of S637 may indirectly modulate the S616 phosphorylation state, possibly due to their proximity within the 3D structure of DLP1, and thus S616 could also be partially involved in the mechanism of mitochondrial fragmentation under G q PCR stimulation. Indeed, it has been proposed for neurological diseases that the DLP1 S616/S637 phosphorylation ratio regulates pathogenesis (DuBoff et al. 2012; Kim et al. 2014) . Using YFP-tagged WT and mutant DLP1 combined with immunoprecipitation, we found that the phosphorylation level of S616 in the DLP1-S637A mutant significantly decreased after Phe stimulation although the phosphorylation state of S616 in WT-DLP1 is unchanged before and after stimulation ( Fig. 8A and B) , although Wang and his colleagues showed that the phosphorylation state of S616 in DLP1 is not likely to influence basal phosphorylation levels of the S637 site using DLP1-S616A (Xu et al. 2016) . One could speculate that the basal S637 phosphorylation state is critical for maintaining S616 basal phosphorylation, indicating that a priming phosphorylation at S637 is required for S616 phosphorylation. J Physiol 596.5 et al. 2009 ). Since we did not observe the effect of PKD inhibition in adult ventricular myocytes here, it is still unclear whether the constitutive activation of G q that occurs in the TG model leads to increases in PKD activity and p-DLP1 at S637 directly, or if this is secondary effect of HF. Animal models such as cardiac-specific DLP1-S637A overexpression or PKD knockout mice will be required for further exploring the role of PKD-dependent DLP1 phosphorylation in cardiac pathophysiology in vivo.
Conclusion
This study is the first to identify a novel PKD-specific substrate DLP1 in mitochondria and delineate the functional role of PKD in cardiac mitochondria. Elucidation of the molecular mechanisms by which PKD-dependent enhanced fission mediates cardiac mitochondrial injury will provide novel insights into the relationship among mitochondrial form, function and G q PCR signalling.
